Thymol
Active ingredient
Sold as FemiClear Infection…
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Topical
- Markets covered
- 2
- Products on record
- 2
- FDA reports (12 mo)
- 8
Overview
Plain-language summary, compiled from the cited regulatory records
Thymol is an ingredient used in products intended to help prevent bacterial vaginosis (BV) and yeast infections, and to moisturize [1]. It is also used to moisturize [1].
This ingredient is available under brand names such as FemiClear Infection Protection [1]. In the past 12 months, there have been 8 adverse event reports associated with products containing this ingredient [2]. The most frequently reported adverse events include drug abuse, disease progression, chills, colitis, and confusional state [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | October 20, 2025 |
| GB United Kingdom | MHRA | 1 | November 8, 2019 |
USUnited States· FDA
1 product
Uses
This product is intended to help prevent bacterial vaginosis (BV) and yeast infections, and to moisturize.
How to take
GBUnited Kingdom· MHRA
1 product
Uses
As a gargle and mouthwash it is taken orally but not swallowed.
How to take
Sources & citations
- [1]FDA DailyMed · 018ed162-4b07-3d… · revised October 20, 2025 [PDF]
- [2]MHRA (UK) · PL183740021 · revised November 8, 2019
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.